Micro diffusimeter (µDiff)
The µDiff is an innovative tool for drug dissolution and diffusion testing, designed to improve pharmaceutical development by providing accurate, reproducible results with less reliance on animal testing. It includes scalable insert technology for in vitro studies and has potential for integration with data analysis platforms to streamline drug research and regulatory processes.
Business Opportunity
Our technology represents a novel solution for drug dissolution and diffusion testing, addressing critical challenges in early-stage pharmaceutical development. Current practices often lack scalability, precision, and sustainability, with a high reliance on animal models. The µDiff approach offers a reproducible and standardized insert system designed for in vitro testing and enabling increased efficiency and reduced costs compared to traditional methods.
The global in vitro absorption, distribution, metabolism, and excretion (ADME) testing market is growing, driven by demands for faster and more reliable drug development processes, and is projected to reach billions of dollars in value by 2030. Within this context, the µDiff technology has the potential to gain significant traction, supporting better prediction of drug behavior and accelerating development timelines. Its business model centers on hardware scalability complemented by optional SaaS-based data solutions, packed in a compelling subscription service.
Commercialization is backed by a strong intellectual property position, industrial compatibility, and scalability. We have had significant interest from the industry for our cost-efficient, robust solution for drug bioavailability studies. The combination of cost-effective testing, reproducibility, reduced reliance on animal studies, and alignment with regulatory requirements makes this a compelling opportunity to disrupt and add value to the drug development market while addressing unmet needs in the industry.
Technology Description
We have developed a precision tool for drug dissolution and diffusion testing, offering standardized, reproducible measurements critical for pharmaceutical development. At its core, µDiff employs a specifically designed insert system that fits into standard laboratory equipment to simplify integration into existing workflows. The system enables high-throughput screening of drug permeability and release rates under controlled conditions, successfully simulating in vivo environments without relying on animal models.
Fig. 1: A standard UV-VIS spectrophotometer is used to evaluate drug dissolution and diffusion.
Intellectual Property
Patent pending.